[1]
Pradelli, L. and Ascierto, P. 2017. [Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]. Farmeconomia. Health economics and therapeutic pathways. 18, 1 (Sep. 2017). DOI:https://doi.org/10.7175/fe.v18i1.1329.